Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dondrium vulgare
- Development stage
- Unknown
- Administration
- Oral
01
Overview
Dondrium vulgare is a botanical ingredient, identified in the context as part of the Qingbu Weijing Decoction. It is likely an alternative or transliterated name for 'Dong Gua Ren' (冬瓜仁), which is Winter Melon Seed (*Benincasa hispida* seed), a commonly used ingredient in Traditional Chinese Medicine. The decoction containing Dondrium vulgare is being investigated for the treatment of bronchiectasis.
- Other names
- Dong Gua RenWinter Melon SeedSemen BenincasaeBenincasa hispida seed
02
Targets
IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)JUN (Transcription factor Jun)TGFB1 (Transforming growth factor Beta-1 proprotein)
Beyond the preview
Go deeper on dondrium vulgare.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dondrium vulgare.